Replies to post #26408 on PharmaCyte Biotech Inc (PMCB)

[HighHoeSilverado]

I consider NVLX a stock in deep decline since march. Too bad most longs accumulated to early

[Traderintx]

If NVLX is a hidden gem the market has a funny way of illustrating that. Stock is down 32% since clinical trials have started. If you are a long term believer in the company you will have a chance to average your position down when the PPS gets down to .05 or below IMHO.